Shandong Wohua Pharmaceutical Co., Ltd.

SZSE:002107 Stock Report

Market Cap: CN¥2.3b

Shandong Wohua Pharmaceutical Past Earnings Performance

Past criteria checks 1/6

Shandong Wohua Pharmaceutical's earnings have been declining at an average annual rate of -2.5%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 2.4% per year. Shandong Wohua Pharmaceutical's return on equity is 3.9%, and it has net margins of 4.8%.

Key information

-2.5%

Earnings growth rate

-2.9%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate2.4%
Return on equity3.9%
Net Margin4.8%
Next Earnings Update03 Aug 2024

Recent past performance updates

Shandong Wohua Pharmaceutical's (SZSE:002107) Conservative Accounting Might Explain Soft Earnings

Apr 05
Shandong Wohua Pharmaceutical's (SZSE:002107) Conservative Accounting Might Explain Soft Earnings

Recent updates

Shandong Wohua Pharmaceutical's (SZSE:002107) Conservative Accounting Might Explain Soft Earnings

Apr 05
Shandong Wohua Pharmaceutical's (SZSE:002107) Conservative Accounting Might Explain Soft Earnings

Subdued Growth No Barrier To Shandong Wohua Pharmaceutical Co., Ltd. (SZSE:002107) With Shares Advancing 28%

Mar 08
Subdued Growth No Barrier To Shandong Wohua Pharmaceutical Co., Ltd. (SZSE:002107) With Shares Advancing 28%

Revenue & Expenses Breakdown

How Shandong Wohua Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002107 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 248904357038
31 Dec 239105956745
30 Sep 239788659748
30 Jun 231,0048961153
31 Mar 2399110657752
01 Jan 231,01510759050
30 Sep 2298410655546
30 Jun 2293111850544
31 Mar 2295013949549
01 Jan 2294316347247
30 Sep 2196717549256
30 Jun 211,03719051554
31 Mar 211,04118652649
31 Dec 201,00617951047
30 Sep 2096918547343
30 Jun 2092615548144
31 Mar 2089112647453
31 Dec 198609648452
30 Sep 198575153156
30 Jun 198343953156
31 Mar 197774249747
31 Dec 187744649240
30 Sep 187714248831
30 Jun 187595944529
31 Mar 187545544519
31 Dec 177275742316
30 Sep 17653673729
30 Jun 17612593580
31 Mar 17589523530
31 Dec 16563493360
30 Sep 16552533220
30 Jun 16516562980
31 Mar 16486662630
31 Dec 15469712470
30 Sep 15463872360
30 Jun 15461792400
31 Mar 15481622610
31 Dec 14438432500
30 Sep 14384222320
30 Jun 14338132240
31 Mar 14266111900
31 Dec 13256111870
30 Sep 13248101840

Quality Earnings: 002107 has high quality earnings.

Growing Profit Margin: 002107's current net profit margins (4.8%) are lower than last year (10.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002107's earnings have declined by 2.5% per year over the past 5 years.

Accelerating Growth: 002107's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002107 had negative earnings growth (-59.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-0.8%).


Return on Equity

High ROE: 002107's Return on Equity (3.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.